Q-omics provides the consensus-scored DUX4L28 profile across patient tissues and cancer cell-line models. DUX4L28 expression is associated with patient survival in 4 of 34 cancer types, with the highest sampling consensus in LAML. Additionally, DUX4L28 RNA expression shows 2,612 significant gene co-expression associations, with the highest sampling consensus in LUSC. Together, these results highlight LAML, and LUSC as cancer lineages where DUX4L28 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.